ArticleslgStudy

biology

Omidubicel

Omidubicel is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Omidubicel rather than just read about it. In short: Omidubicel, sold under the brand name Omisirge, is a blood-based cell therapy used for the treatment of blood cancers, and severe aplastic anemia. Omidubicel is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood.

Key takeaways

  • Omidubicel belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Omidubicel to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Omidubicel from memory before moving on to harder problems.

Reference excerpt

Omidubicel, sold under the brand name Omisirge, is a blood-based cell therapy used for the treatment of blood cancers, and severe aplastic anemia. Omidubicel is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood. The most common adverse reactions include infections, graft-versus-host disease, and infusion reactions. Omidubicel is composed of human allogeneic stem cells from umbilical cord blood that are processed and cultured with nicotinamide (a form of vitamin B3). Each dose is patient-specific, containing healthy stem cells from an allogeneic pre-screened donor, meaning it comes from a different individual rather than using the patient's own cells. Omidubicel was approved for medical use in the United States in April 2023.

Medical uses Omidubicel is indicated for use in people twelve years of age and older with blood cancers (hematologic malignancies) planned for umbilical cord blood transplantation following myeloablative conditioning to reduce the time to neutrophil recovery and the incidence of infection; and for use in people six years of age and older with severe aplastic anemia following reduced intensity conditioning.

History The US Food and Drug Administration (FDA) evaluated the safety and effectiveness of omidubicel based on a randomized, multicenter study comparing transplantation of omidubicel to transplantation of umbilical cord blood, in subjects between the ages of 12 and 65 years. The study enrolled a total of 125 participants. All participants in the study had confirmed blood cancers. The efficacy of omidubicel was based on the amount of time needed for recovery of the participant's neutrophils (a type of white blood cell that helps protect the body from infections) and the incidence of infections following transplantation. In total, 125 participants were randomized--62 participants to receive omidubicel-onlv and 63 to the unmanipulated cord blood group. Fifty-two participants were transplanted with omidubicel-onlv receiving a median CD34+ cell dose of 9.0 X 106 cells/kg (range 2.1 – 47.6 X 106 cells/kg). Fifty-six participants were transplanted in the unmanipulated cord blood arm with one or two cord units (66% received two cord units). In the 42 participants with reported post-thaw cell dose, the median CD34+ cell dose was 0.2 X 106 cells/kg (range 0.0 – 0.8 X 106 cells/kg). Multiple conditioning regimens were used, including total body irradiation-based or chemotherapy-based options. The FDA granted the application for omidubicel priority review, breakthrough therapy, and orphan drug designations. The FDA granted regular approval of Omisirge to Gamida Cell Ltd.

References

External links Clinical trial number NCT02730299 for "Stem Cell Transplantation With NiCord (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS" at ClinicalTrials.gov

Worked examples

Example 1 — a first encounter with Omidubicel

Start with the simplest possible case. Write down what Omidubicel claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Omidubicel before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Omidubicel ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Omidubicel

In research
Omidubicel appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Omidubicel in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Omidubicel is common in secondary-school and first-year university syllabi. It links to neighbouring topics Cell therapies, Drugs not assigned an ATC code, Orphan drugs, so understanding it makes those chapters shorter.
In everyday life
Look for Omidubicel outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Omidubicel” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Omidubicel in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Omidubicel means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Omidubicel out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Omidubicel in simple terms?

Omidubicel, sold under the brand name Omisirge, is a blood-based cell therapy used for the treatment of blood cancers, and severe aplastic anemia. Omidubicel is a nicotinamide-modified allogeneic hematopoietic progenitor cell therapy derived from cord blood.

Why does Omidubicel matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Omidubicel?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Omidubicel.

Tags

  • Cell therapies
  • Drugs not assigned an ATC code
  • Orphan drugs

Keep exploring